8-K/A
filed January 12, 2026, 6:59 PM ET
ticker JAGX
CIK 0001585608
debt
confidence high
sentiment neutral
materiality 0.40
Jaguar Health, Inc. (JAGX): debt financing — Jaguar Health issues $350K in 6% notes with warrants; corrects prior filing dates
Jaguar Health, Inc.
- Issued $350,000 aggregate principal amount of 6% unsecured promissory notes to two accredited investors.
- Warrants to purchase up to 350,000 shares at $1.00 per share, exercisable immediately, expire in 5 years.
- Proceeds used for working capital and general corporate purposes; transaction closed on January 6, 2026.
- This 8-K/A corrects scrivener's errors in the original filing regarding execution and closing dates.
Key facts
Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
Jaguar Health, Inc. incurred loan of $350,000 aggregate principal amount with two accredited investors at 6% per annum maturing one month after issuance.
- Instrument
- loan
- Principal
- $350,000 aggregate principal amount
- Counterparty
- two accredited investors
- Rate
- 6% per annum
- Maturity
- one month after issuance
- Event
- incurrence
Exact text from the filing
On January 6, 2026 (the “Execution Date”), Jaguar Health, Inc. (the “Company”) entered into securities purchase agreements (the “Securities Purchase Agreements”) with two accredited investors (each, an “Investor”), pursuant to which the Company issued $350,000 aggregate principal amount of unsecured promissory notes (collectively, the “Notes”) to such Investors.
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Jaguar Health, Inc. issued up to an aggregate of 350,000 shares of warrant to two accredited investors for initial exercise price equal to $1.00 per share.
- Security
- warrant
- Shares
- up to an aggregate of 350,000 shares
- Purchaser
- two accredited investors
- Consideration
- initial exercise price equal to $1.00 per share
Exact text from the filing
of 350,000 shares (the “Warrant Shares”) of the Company’s voting common stock, par value $0.0001 per share (the “Common Stock”), with an initial exercise price equal to $1.00 per share, subject to adjustment for reclassification of the Common Stock, non-cash dividend, stock split, reverse stock split or other similar transaction (the “Exercise Price”).
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Jaguar Health, Inc. issued convertible note to two accredited investors for $350,000 aggregate principal amount.
- Security
- convertible note
- Purchaser
- two accredited investors
- Consideration
- $350,000 aggregate principal amount
Exact text from the filing
the Company issued $350,000 aggregate principal amount of unsecured promissory notes (collectively, the “Notes”) to such Investors.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Jaguar Health, Inc. entered into Securities Purchase Agreements with two accredited investors valued at $350,000 aggregate principal amount (effective 2026-01-06).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- two accredited investors
- Value
- $350,000 aggregate principal amount
- Effective
- 2026-01-06
Exact text from the filing
On January 6, 2026 (the “Execution Date”), Jaguar Health, Inc. (the “Company”) entered into securities purchase agreements (the “Securities Purchase Agreements”) with two accredited investors (each, an “Investor”), pursuant to which the Company issued $350,000 aggregate principal amount of unsecured promissory notes (collectively, the “Notes”) to such Investors.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.